Current Drug Targets

Papers
(The H4-Index of Current Drug Targets is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Current Research Trends in Cytokine Storm: A Scientometric Study45
Meet the Editorial Board Member37
Cell Entry and Unusual Replication of SARS-CoV-235
Meet the Editorial Board Member34
SARS-Coronavirus 2, A Metabolic Reprogrammer: A Review in the Context of the Possible Therapeutic Strategies33
Polymeric Micelle-Based Nanogels as Emerging Drug Delivery Systems in Breast Cancer Treatment: Promises and Challenges30
Retracted: Meet the Editorial Board Member27
Unfurling the Potential of Antiviral Agents Aimed for RNA Virus Ailment26
Review on the Drug Intolerance and Vaccine Development for the Leishmaniasis24
The Development of the Combination Drug Leukovir® Tablets for the Treatment of Multiple Sclerosis: A Comprehensive Review24
The Marburg Virus Outbreak in West Africa23
Antibiotic Adjuvants: A Promising Approach to Combat Multidrug Resistant Bacteria22
Metformin: A Promising Antidiabetic Medication for Cancer Treatment22
Meet the Regional Editor22
Meet the Editorial Board Member21
Use of Total Parenteral Nutrition (TPN) as a Vehicle for Drug Delivery21
Current Perspectives of Healthy Mitochondrial Function for Healthy Neurons20
Envisioning Glucose Transporters (GLUTs and SGLTs) as Novel Intervention against Cancer: Drug Discovery Perspective and Targeting Approach20
Xerostomia: Advances and Challenges in Drug Development20
Venom of Viperidae: A Perspective of its Antibacterial and Antitumor Potential19
Targeted Delivery Strategies of Herbal-Based Nanogels: Advancements and Applications19
Regulation of Tumor Immune Microenvironment by Sphingolipids and Lysophosphatidic Acid19
Targeting Neurodegeneration: The Emerging Role of Hybrid Drugs19
An Updated Review for the Diabetic Wound Healing Systems19
Gamma Secretase Inhibitor: Therapeutic Target via NOTCH Signaling in T Cell Acute Lymphoblastic Leukemia19
0.18903517723083